RINI CHENNATTU: Open Payments
NPI 1417432394 · CORTLAND, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,135 in 40 payments from 9 companies in 2025. Trend: 2023 $1,057 · 2024 $1,001 · 2025 $1,135
Food & beverage: $1,023Education: $111
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $564 |
| Teva Pharmaceuticals USA, Inc. | 6 | $186 |
| Janssen Pharmaceuticals, Inc | 3 | $162 |
| E.R. Squibb & Sons, L.L.C. | 4 | $73 |
| Alkermes, Inc. | 3 | $50 |
| Neurocrine BioSciences, Inc. | 2 | $46 |
| Axsome Therapeutics, Inc. | 1 | $21 |
| Braeburn Inc. | 1 | $17 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $15 |
Products named: VRAYLAR, INVEGA SUSTENNA, COBENFY, AUSTEDO XR, ARISTADA, INGREZZA, INVEGA, Auvelity.
Industry payments across NY — which companies pay providers there.
